New antibody targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This study tests a new antibody drug, OM-RCA-01, in people with advanced cancers that have a specific protein called FGFR1. The goal is to see if the drug is safe and can slow tumor growth. About 58 adults with kidney, lung, prostate, breast, or head & neck cancer will receive th…
Phase: PHASE1, PHASE2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control
Last updated May 04, 2026 16:24 UTC